Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease
Aleksander Turk, Tanja Kunej, Borut Peterlin
Journal of Personalized Medicine (2021) Vol. 11, Iss. 12, pp. 1275-1275
Open Access | Times Cited: 17

Showing 17 citing articles:

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 76
Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic model
Yanting Zhang, Hisanori Kiryu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Wanran Li, Yun Zheng
Cells (2023) Vol. 12, Iss. 10, pp. 1378-1378
Open Access | Times Cited: 15
DECIPHERING THE ROLE OF miRNAs IN ALZHEIMER'S DISEASE: PREDICTIVE TARGETING AND PATHWAY MODULATION - A SYSTEMATIC REVIEW
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Ageing Research Reviews (2024) Vol. 101, pp. 102483-102483
Closed Access | Times Cited: 4
microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders
Mozhgan Abasi, Anvarsadat Kianmehr, Atena Variji, et al.
Neuroscience (2025)
Closed Access
Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs
Marissa Alvarez, Erick Trent, Bruno de Souza Gonçalves, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
Common molecular and pathophysiological underpinnings of delirium and Alzheimer’s disease: molecular signatures and therapeutic indications
Md. Parvez Mosharaf, Khorshed Alam, Jeff Gow, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Non-Coding RNAs in the Regulation of Hippocampal Neurogenesis and Potential Treatment Targets for Related Disorders
Zhengye Tan, Wen Li, Xiang Cheng, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 18-18
Open Access | Times Cited: 12
Argonaute protein assisted drug discovery for miRNA-181c-5p and target gene ATM translation repression: a computational approach
Harshita Tak, Jivanage Anirudh, Arpan Chattopadhyay, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 2
Extracellular vesicle-packed microRNAs profiling in Alzheimer’s disease: The molecular intermediary between pathology and diagnosis
S. H. Arif, Talal Jamil Qazi, Zhenzhen Quan, et al.
Ageing Research Reviews (2024), pp. 102614-102614
Closed Access | Times Cited: 2
NF-kB (p50/p65)-Mediated Pro-Inflammatory microRNA (miRNA) Signaling in Alzheimer's Disease (AD)
Walter J. Lukiw
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro
Isidora Rovčanin Dragović, Nataša Popović, Maša Ždralević, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 2, pp. 625-638
Closed Access | Times Cited: 9
APOE ε4 in Depression-Associated Memory Impairment—Evidence from Genetic and MicroRNA Analyses
Sarah Bonk, Kevin Kirchner, Sabine Ameling, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1560-1560
Open Access | Times Cited: 8
Can Genetic Markers Predict the Sporadic Form of Alzheimer’s Disease? An Updated Review on Genetic Peripheral Markers
D. Theron, Lloyd N. Hopkins, Heidi G. Sutherland, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13480-13480
Open Access | Times Cited: 2
Unlocking the Memory Component of Alzheimer’s Disease: Biological Processes and Pathways across Brain Regions
Nikolas Dovrolis, Maria Nikou, Alexandra Gkrouzoudi, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 263-263
Open Access | Times Cited: 3
Specific Role of Extracellular Vesicles in Controlling Neuroinflammation in Alzheimer’s and Parkinson’s Disease: Is an EV-Based Therapy Possible?
Syamantak Ghosh, Sourav Hom Choudhury, Kamalika Mukherjee, et al.
NeuroImmune Pharmacology and Therapeutics (2024), pp. 265-282
Closed Access
Argonaute protein assisted drug discovery for miRNA-181c-5p and target gene ATM translation repression: a computational approach
Harshita Tak, Jivanage Anirudh, Arpan Chattopadhyay, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top